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Abstract
Background: Mannheimia haemolytica typically resides in cattle as a commensal member of the upper respiratory
tract microbiome. However, some strains can invade their lungs and cause respiratory disease and death, including
those with multi-drug resistance. A nucleotide polymorphism typing system was developed for M. haemolytica from
the genome sequences of 1133 North American isolates, and used to identify genetic differences between isolates
from the lungs and upper respiratory tract of cattle with and without clinical signs of respiratory disease.
Results: A total of 26,081 nucleotide polymorphisms were characterized after quality control filtering of 48,403
putative polymorphisms. Phylogenetic analyses of nucleotide polymorphism genotypes split M. haemolytica into
two major genotypes (1 and 2) that each were further divided into multiple subtypes. Multiple polymorphisms
were identified with alleles that tagged genotypes 1 or 2, and their respective subtypes. Only genotype 2 M. haemolytica
associated with the lungs of diseased cattle and the sequence of a particular integrative and conjugative element (ICE).
Additionally, isolates belonging to one subtype of genotype 2 (2b), had the majority of antibiotic resistance genes
detected in this study, which were assorted into seven combinations that ranged from 1 to 12 resistance genes.
Conclusions: Typing of diverse M. haemolytica by nucleotide polymorphism genotypes successfully identified
associations with diseased cattle lungs, ICE sequence, and antibiotic resistance genes. Management of cattle
by their carriage of M. haemolytica could be an effective intervention strategy to reduce the prevalence of
respiratory disease and supplemental needs for antibiotic treatments in North American herds.
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Background
Bovine respiratory disease (BRD) is a worldwide animal
health and welfare problem that costs the United States
cattle industry over one billion dollars annually [1–4].
Multiple viral and bacterial pathogens, as well as host
and environmental factors either cause or contribute to
BRD (reviewed in [5]). M. haemolytica is a predominant
bacterial agent of BRD that causes severe fibrinonecrotic
pneumonia in both beef and dairy cattle [3, 6] and his-
torically has been the bacteria species most commonly
isolated from the lungs of cattle afflicted with respiratory
disease [5, 7–9].
M. haemolytica is an opportunistic pathogen that
often resides in the upper respiratory tract of cattle as a
commensal, and invades the lower respiratory tract
when animals are immunocompromised by viral infec-
tions, stress, or other factors (reviewed in [10]). Typing
of M. haemolytica strains based on capsular phenotypes
and pulsed-field gel electrophoresis (PFGE) have both
indicated that M. haemolytica is comprised of distinct
sub-species, or strain types, that do not all equally asso-
ciate with BRD [10]. Strains with either A2 or A4 capsu-
lar serotypes have been more frequently isolated from
the upper respiratory tracts of cattle without signs of re-
spiratory disease, while strains with A1 or A6 serotypes
have been more frequently isolated from the lungs and
nasopharynx of diseased animals [3, 10–12]. Similarly, a
dendrogram of PFGE profiles from M. haemolytica
strains isolated from the nasopharynx of cattle with or
without signs of respiratory disease was found to have
two major clusters that disproportionately represented
isolates from animals with and without signs of BRD,
respectively [13].
M. haemolytica strains also demonstrate diverse suscep-
tibility phenotypes to antimicrobials used to treat BRD
cases. Overall, strains isolated from North American cattle
with respiratory disease over the last several decades have
trended towards decreasing susceptibilities to some of the
antimicrobials used for treatment [14–17]. Conversely, M.
haemolytica isolated from the upper respiratory tract of
cattle without clinical signs of respiratory disease have
tended to display lower overall antibiotic resistance than
strains from diseased animals [16].
M. haemolytica and other members of the Pasteurella-
ceae family that cause BRD can harbor plasmids or ICEs
containing antibiotic resistance encoding genes [18–25].
Plasmids containing antibiotic-resistance genes have
been recognized in M. haemolytica for over 30 years
[26]. In contrast, ICEs have been recognized in BRD-
causing pathogens only recently. An ICE was first identi-
fied in Pasteurella multocida in 2012 (ICEPmu1) that
was isolated from a beef calf in Nebraska and contained
two regions encoding a total of 11 antibiotic resistance
genes [22]. Under laboratory conditions, ICEPmu1 was
able to transfer from P. multocida to M. haemolytica by
conjugation and integration [22]. Homologs of ICEPmu1,
such as ICEMh1, have subsequently been identified in
field-collected isolates of M. haemolytica from cattle in
Nebraska, Pennsylvania, and Texas [21, 23, 27, 28]. The
homologs share a conserved backbone that consists of
blocks of genes which are adjacent to antibiotic resistance
gene regions [23]. The number and assortment of anti-
biotic resistance genes vary between homologs, and not all
contain resistance genes. For example, ICEMh1 has five
antibiotic resistance genes, while yet another putative
homolog found in M. haemolytica strain USDA_ARS_US-
MARC 183 has none [23]. Homologs to ICEPmu1 and
ICEMh1 that contain antibiotic resistance genes do not
appear restricted to one geographical region of North
America [21, 27, 29], and may have a wide distribution
and role in M. haemolytica antibiotic resistance. Given
that capsular serotypes and PFGE profiles both indicate
that M. haemolytica strains do not all equally associate
with BRD, it is plausible that homologs containing anti-
biotic resistance genes could be more prevalent in M.
haemolytica strains that associate with disease, as they
would be more frequently exposed to BRD prevention and
control measures that include antimicrobials.
The aim of this study was to investigate M. haemoly-
tica at the subspecies level for associations with diseased
cattle lungs, the conserved backbone of ICEPmu1,
ICEMh1, and other ICE homologs, and antibiotic resist-
ance genes found within variable regions of ICEPmu1
and ICEMh1. Accordingly, there were three major goals.
The first was to sequence the genomes of 857 Mannhei-
mia haemolytica isolates, including isolates from the
lungs of diseased cattle that were located throughout
much of North America, and isolates from the naso-
pharynx of cattle without clinical signs of respiratory
disease. The second was to identify nucleotide polymor-
phisms that type M. haemolytica of North American cat-
tle into well-supported clades using the sequences
generated in this study, and those available from an add-
itional 276 isolates. The third was to test nucleotide
polymorphism-derived clades for associations with the
lungs of cattle with respiratory disease, the conserved
backbone of ICEPmu1, ICEMh1, and other related ho-
mologs, and antibiotic resistance genes harbored on
ICEPmu1 and ICEMh1.
Results
Isolate sequencing coverage and classification into
groups
A total of 857 M. haemolytica isolates from North
American cattle were sequenced to a minimum level of
10× sequence coverage per genome. Another 276 iso-
lates from North American cattle that were previously
sequenced at the same level of coverage were also
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included in this study [29, 30]. The isolates were arranged
into two collections, Zoetis and KSU-USMARC, that each
consisted of two groups (Table 1, Additional file 1).
The two groups of the Zoetis collection (lung clinical
isolates 1 and 2) were each comprised of epidemiologically-
unrelated isolates from the lungs of cattle with BRD,
however, isolates between the groups shared some epi-
demiological relatedness. Within the KSU-USMARC
collection, one group (nasopharyngeal non-clinical isolates)
consisted of non-clinical isolates from the nasopharynx
of cattle without BRD signs that were selected for
minimal epidemiological relatedness. The other group
(clinical and non-clinical isolates) consisted of isolates
from the lungs or nasopharynx of cattle with or without
signs of respiratory disease. Many isolates within the
clinical and nonclinical group were epidemiologically
related to each other.
Identification of nucleotide polymorphisms and M.
haemolytica genotypes 1 and 2
Prior to quality control filtering, 48,403 putative poly-
morphisms were identified from the sequences of all
1133 isolates included in the study. Of those, 26,081
polymorphisms were selected for further analyses that
were not: 1) in duplicated genome or integrated phage
regions of reference M. haemolytica strain USDA-ARS-
USMARC-183, 2) singletons (single observation of alter-
native allele), or 3) ambiguously genotyped for more
than 5% of the isolates. To generate a Neighbor-Joining
tree that would be minimally influenced by missing data,
the 26,081 polymorphisms were additionally screened
for those with allele genotype call rates of 95% or higher
for the 1133 isolates, which yielded 16,447 polymorphisms
(Additional files 2 and 3). The tree of concatenated
polymorphism genotypes depicted two deeply divided
clades with strong bootstrap support (Fig. 1). Of the
16,447 polymorphisms used to generate the tree, 13,941
of them separated the two clades, where each allele was
found exclusively in one of the clades. These two clades
represent two major genotypes of M. haemolytica.
Identification of subtypes and tagging nucleotide
polymorphisms within genotype 1
The original set of 26,081 polymorphisms was re-
evaluated within 521 of 525 genotype 1 isolates classified
in this study to identify polymorphisms suitable for
higher resolution typing of genetic diversity within the
genotype. Four genotype 1 isolates were excluded from
the analysis due to missing data. Of the original 26,081
polymorphisms, 16,888 had a 90% or higher allele call
rate for the 521 isolates (Additional files 4 and 5). A
total of 1710 of the 16,888 polymorphisms were inform-
ative for the identification of subtypes within genotype 1,
meaning that both polymorphism alleles were observed
in genotype 1 isolates (Additional file 6). A phi test for
recombination applied to concatenated polymorphism
alleles of the 521 isolates was positive (p = 0.0). Accord-
ingly, a Neighbor-Joining network, which accounted for
recombination [31], was constructed from concatenated
polymorphism alleles of each isolate (Fig. 2). Five clus-
ters were observed that were all well-supported by
Shimodaira-Hasegawa approximate likelihood ratio test
(SH-aLRT) values that exceeded 80%, and with four of
Table 1 Isolates used for whole genome sequencing and/or analyses
Collection Group # Isolates States/provinces Year/range Statistical test use
Zoetis Lung Clinical Isolates 1 155 35/5 2002–2011 Yesa
Zoetis Lung Clinical Isolates 2 162 29/3 2002–2011 Nob
KSU-USMARC Nasopharyngeal non-Clinical Isolates 35 3/0 2013 Yesc
KSU-USMARC Clinical and non-Clinical Isolatesd 781 4/0 2013 Noe
aUsed for association testing of genotype 2 M. haemolytica with the lungs of cattle with respiratory disease and ICE sequence, and association testing of 2b M.
haemolytica with antibiotic resistance genes encoded by ICEPmu1 and/or ICEMh1
bNot used for statistical tests due to epidemiological overlap with lung clinical isolates group 1
cUsed for association testing of genotype 2 M. haemolytica with the lungs of cattle with respiratory disease and ICE sequence
dRepresented by both lung and nasopharyngeal isolates. Previously sequenced isolates are included in this group (n = 276), [29, 30]. All other isolates of both
collections were sequenced in this study (n = 857)
eNot used for statistical tests due to epidemiological overlap among isolates within the group and with the group of nasopharyngeal non-clinical isolates
Fig. 1 Neighbor-Joining tree of concatenated nucleotide-polymorphism
genotypes from 1133 M. haemolytica isolates. The scale bar represents
substitutions per site. The number within the tree represents bootstrap
level support for the separation of clades one and two
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the clusters additionally supported by ultrafast bootstrap
values exceeding 95%. Of all 525 genotype 1 isolates classi-
fied in this study, 515 (98%) placed unambiguously within
one of the five clusters. Only ten isolates were not confi-
dently placed due to missing data and/or inadequate statis-
tical support within a cluster (Additional file 1). The five
clusters represent 5 genetic divisions, or subtypes of geno-
type 1 M. haemolytica (1b, 1c, 1e, 1f, 1i), (Fig. 2).
Tagging nucleotide polymorphisms were identified for all
five subtypes of genotype 1. These were polymorphisms
where one allele was exclusively observed in all isolates of
a particular subtype: (1b; n = 153), (1c; n = 2), (1e; n = 106),
(1f; n = 5), (1i; n = 349), (Additional file 6). Many of the tag-
ging polymorphism were identified in close proximity to
each other, indicating probable sites of recombination [32].
Identification of subtypes and tagging polymorphisms
within genotype 2
The original set of 26,081 polymorphisms was also re-
evaluated within 600 of 608 genotype 2 isolates classified
in this study to identify polymorphisms suitable for
higher resolution typing of genetic diversity within geno-
type 2. Eight genotype 2 isolates were excluded from the
analysis due to missing data. From the initial 26,081
polymorphisms, 24,475 had alleles observed at a fre-
quency of 90% or higher for the 600 genotype 2 isolates.
(Additional file 5). A total of 3499 of the polymorphisms
were informative for genotype 2 (Additional files 7 and 8).
As in genotype 1, the concatenated polymorphism alleles
of genotype 2 isolates tested strongly positive for recom-
bination (phi test p = 0.0). A Neighbor-Joining network
constructed from the concatenated polymorphism allele
genotypes of each of the 600 isolates yielded 5 clusters
that were all well supported by both SH-aLRT and ultra-
fast boot strap values (Fig. 3). Four clusters were assigned
as subtype representatives (b, c, d, e). The one cluster not
assigned to a subtype was primarily a 2b subtype that had
recombined with either a 2c, 2d, or 2e subtype (designated
*b 2 (c, d, or e) in Fig. 3), and was only represented by the
concatenated nucleotide polymorphism genotypes of
three isolates (Additional file 1). Recombination was
also detected between subtypes 2b and 2d, as well as
subtypes 2d and 2e (Fig. 3).
A total of 598 of all 608 genotype 2 isolates classified in
this study (98%) unambiguously placed in subtypes b, c, d,
or e, or were identified as recombinants between the four
Fig. 2 Neighbor-Joining network of concatenated nucleotide-
polymorphism genotypes from 521 M. haemolytica genotype 1
isolates. Letters and ellipsoids within the network represent subtypes
and their boundaries, respectively. Non-italicized numbers within the
network represent maximum-likelihood support, and italicized num-
bers represent bootstrap support. The asterisk represents recom-
binant sequence of 2e on the backbone of 1b. The scale bar
represents substitutions per site
Fig. 3 Neighbor-Joining network of concatenated nucleotide-polymorphism genotypes from 600 M. haemolytica genotype 2 isolates. Letters and
ellipsoids within the network represent subtypes and their boundaries, respectively. Non-italicized numbers within the network represent maximum-
likelihood support, and italicized numbers represent bootstrap support. The scale bar represents substitutions per site. Asterisks indicate recombination:
(2b with 2d), (2b with 2c, 2d, or 2e), (2d with 2e)
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subtypes. Ten genotype 2 isolates were not assigned sub-
types due to missing data and/or lack of statistical support
within a cluster. Tagging polymorphisms were identified
for subtype 2b (n = 1574), 2c (n = 7), and 2d (n = 158),
(Additional file 9). None were found for subtype 2e, which
could represent an ancestral state to the other subtypes.
Association of genotype 2 M. haemolytica with the lungs
of cattle with respiratory disease
Of the 155 isolates comprising group 1 of lung clinical
isolates, 150 had genotype 2 and five had genotype 1. In
comparison, of the 35 isolates comprising the nasopha-
ryngeal non-clinical isolate group, six had genotype 2
and 29 had genotype 1 (Fischer’s exact test p <0.001, Odds
Ratio = 145, CI95% 36–647), (Fig. 4, Additional file 1).
Thus, genotype 2 M. haemolytica strongly associated with
the lungs of cattle with respiratory disease. Notably, a
similar frequency of genotype 2 was also found in group 2
of lung clinical isolates. Of 162 isolates within the group,
152 had genotype 2 and ten had genotype 1.
Association of genotype 2 M. haemolytica with ICE sequence
Of 190 isolates comprising group 1 of lung clinical iso-
lates and the nasopharyngeal non-clinical isolate group,
154 of 156 genotype 2 isolates had sequence homolo-
gous to the conserved backbone of ICEPmu1, ICEMh1,
and other related homologs. Conversely, 33 of 34 geno-
type 1 isolates did not (Additional file 1, Fig. 4, Fischer’s
exact test p <0.001, Odds Ratio = 2541, CI95% 186–91,615).
Consequently, genotype 2 M. haemolytica associated with
the conserved ICE backbone. A similar distribution was
also observed in group 2 lung clinical isolates, where 150
of 152 genotype 2 isolates had the conserved ICE back-
bone, and eight of ten genotype 1 isolates did not.
Association of genotype 2, subtype b (2b) M. haemolytica
with antibiotic resistance genes encoded by ICEPmu1 or
ICEMh1
Nasopharyngeal non-clinical isolates were not included
for association tests in this category as only six of them
were genotype 2. Within 147 group 1 lung clinical isolates
that were genotype 2 and subtyped with maximum likeli-
hood significance, 80 were 2b and 67 were either 2c, 2d,
or 2e. All 80 2b isolates were positive for one or more of
the antibiotic resistance genes encoded by ICEPmu1 or
ICEMh1. Conversely, 66 out of the 67 genotype 2c, 2d, or
2e isolates were negative for all of the same antibiotic
genes (Additional file 1, Fig. 5, Fischer’s exact test p
<0.001, Odds Ratio =∞, CI95% 408–∞). Within the 147
group 2 lung clinical isolates that were genotype 2 and
subtyped with maximum likelihood significance, 69 were
2b and 78 were either 2c, 2d, or 2e. All 69 2b isolates were
positive for at least one of the antibiotic resistance genes
encoded by ICEPmu1 or ICEMh1. Conversely, all 78 iso-
lates that were either 2c, 2d, or 2e were negative for the
genes. Thus, 99% of the 194 tested isolates within the two
lung clinical isolates groups that had antibiotic resistance
genes encoded by ICEPmu1 or ICEMh1 were 2b, and the
frequency of 2b isolates with one or more antibiotic resist-
ance gene within both groups was 100%.
Linkage of antibiotic resistance genes in 2b isolates
Every 2b isolate in this study (n = 312) had the gene tet(H)
(Additional file 1, Fig. 6), which encodes resistance to
a c
b
Fig. 4 M. haemolytica genotype 2 associations. Section (a) shows a 2-by-2 table of 190 isolates categorized by their genotypes and origin from either
the lungs of cattle with respiratory disease or the nasopharynx of cattle without signs of respiratory disease, and the association of genotype 2 M.
haemolytica with the lungs of cattle with respiratory disease. Section (b) shows a 2-by-2 table of the same 190 isolates categorized by
their genotypes and the presence or absence of the conserved sequence backbone of ICEPmu1 and ICEMh1. The table also shows the association
of genotype 2 M. haemolytica with the conserved ICE backbone. Section (c) shows traits of genotype 1 and 2 M. haemolytica. The tree is
a duplication of Fig. 1
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tetracycline [33], as well as a copy of its repressor gene
tet(R), (data not shown). Additionally, there was complete
linkage of the genes aphA1, strB, strA and sul2 within all
2b isolates of the study. A total of 151 2b isolates were
positive for aphA1, strB, strA and sul2, including 128 from
groups 1 and 2 of lung clinical isolates. Conversely, 161 2b
isolates were negative for aphA1, strB, strA and sul2
(Additional file 1). Collectively, these genes encode resist-
ance to the aminogylcosides (kanamycin and neomycin
(aphaA1) and streptomycin (strA and strB)), and the
sulphonamide sulfamethoxazole (sul2), [23]. Within the
lung clinical isolate groups, linkage was also observed be-
tween the genes aadB, aadA15, floR, blaOXA-2, erm(42),
msrE, and mphE, although it was not perfect among the
37 2b isolates from both groups that were positive for
some or all of the genes (Additional file 1). Collectively,
the genes encode for resistance to the aminoglycosides
gentamicin (aadB), streptomycin and spectinomycin
(aadA15), chloramphenicol and florfenicol (floR), some
ß-lactams (blaOXA-2), and macrolides erm(42), msrE,
and mphE).
All 12 antibiotic resistance genes encoded by ICEPmu1
or ICEMh1 occurred as one of seven different antibiotic
resistance gene combinations identified within all 2b
isolates of this study (Fig. 7, Additional file 1). The tet(H)
gene was present on all seven different combinations
Fig. 5 Association of M. haemolytica 2b with one or more antibiotic resistance gene found within the variable regions of ICEPmu1 or ICEMh1.
Group 1 lung clinical isolates that were genotype 2 (N = 147) were used for the association test. The single asterisk denotes genotype 2b that
contains recombinant sequence. The network is a duplication of Fig. 3
a b
Fig. 6 Frequencies of antibiotic resistance genes that mapped to variable regions of ICEPmu1 or ICEMh1 in M. haemolytica 2b. The frequencies
represent: a group 1 lung clinical isolates and b group 2 lung clinical isolates
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which accounted for 100% frequency of the gene in 2b
isolates. While the genes aphA1, strB, strA and sul2 were
perfectly linked to each other, they co-occurred in five
different combinations, with combination one being the
most frequent within groups 1 and 2 of lung clinical iso-
lates. Combination one consisted of aphA1, strB, strA,
sul2, and tet(H) and was observed in lung clinical isolates
which were obtained between 2002 and 2011 from diag-
nostic labs in three Canadian provinces and 27 US States.
Combination one was additionally observed in 2b isolates
of other groups that were obtained from cattle in Tennes-
see, Missouri, and Kentucky in 2013 (Additional file 1).
Combination two, which had the second highest fre-
quency in lung clinical isolate groups 1 and 2, contained
all 12 antibiotic resistance gene (Fig. 7). This combination
was found in 21 isolates that originated from diagnostic
labs in 12 US states between the years 2003 and 2011. The
earliest observation of this combination was in a 2003 iso-
late from a diagnostic lab in Oklahoma (Additional file 1).
Thus, combination two, which encodes resistance to ami-
noglycosides, sulphonamide, phenicols, tetracycline, β
-lactams, and macrolides, has been in circulation in the
U.S. for over a decade.
Discussion
A novel SNP-based classification system for M. haemoly-
tica of North American cattle was developed in this
study. Two major genotypes that both further divide into
multiple subtypes were identified. The two genotypes
significantly differ by their associations with the lungs of
cattle with respiratory disease and ICE sequence hom-
ologous to the conserved backbone of ICEPmu1 and
ICEMh1. Additionally, just one subtype of genotype 2
associated with antibiotic resistance genes carried on
ICEPmu1 or ICEMh1. However, it is important to
recognize how the isolates used to identify the associations
differed from each other, that their history was not fully
known regarding antibiotic exposure or lack thereof, and
thus the context and some caveats regarding the associa-
tions identified in this study.
Both anatomical location and animal disease status
differed between isolates of the two groups used for as-
sociation tests involving genotypes 1 and 2, which were
group 1 of lung clinical isolates and the group of non-
clinical nasopharyngeal isolates. Group 1 of lung clinical
isolates consisted of isolates from the lungs of cattle with
respiratory disease, whereas the group of nasopharyngeal
non-clinical isolates consisted of non-clinical isolates
from the nasopharynx of cattle without signs of respira-
tory disease. Consequently, the genotype 2 association is
with the lungs of cattle with respiratory disease, as op-
posed, for example, to just respiratory disease exclu-
sively, or the lungs exclusively. By extension, the ICE
sequence association with genotype 2 is also linked to
the lungs of cattle with respiratory disease.
The two groups also differed by their depth of isolates
across time and space. Group 1 of lung clinical isolates
consisted of 155 isolates that represented 35 U.S. States
and 5 Canadian Provinces from the years 2002–2011.
Conversely, the group of nasopharyngeal non-clinical
isolates represented three U.S. states and the year 2013.
Given that genotype 2 was the predominant genotype of
the lung clinical isolates, whereas genotype 1 was the
predominant genotype of the nasopharyngeal non-clinical
isolates, genotype 2 was well represented in the study.
However, it is quite possible that genotype 1 North
a
b c
Fig. 7 Unique combinations of antibiotic resistance genes and their frequencies in M. haemolytica 2b isolates from groups 1 and 2 of lung clinical
isolates. Section (a) shows the seven combinations identified in this study. Plus signs indicate the gene is present, minus signs indicate the gene is not.
Sections (b) and (c) show the combination frequencies in 2b isolates of groups 1 and 2 of lung clinical isolates, respectively
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American M. haemolytica have more subtypes than
those presently characterized, due to limited geograph-
ical and temporal representation of genotype 1 diversity
in this study.
Additionally, for both groups used for association test-
ing involving genotypes 1 and 2, the antibiotic treatment
history of cattle from which the isolates originated was
unknown. Given that the 155 cattle from which the
group 1 lung clinical isolates were obtained were
afflicted with respiratory disease at the time they were
sampled, it is likely that some may have received anti-
biotic treatments prior to sampling. It is also not known
whether any of the 35 cattle from which the nasopharyn-
geal non-clinical isolates were obtained received antibi-
otics prior to their sampling at sale barn locations.
Disparate antibiotic exposure between isolates could
have influenced ICE or genotype frequency differences
between the two groups.
Although additional subtype diversity not observed in
this study may exist within genotype 1 M. haemolytica
of North America, it is unlikely that this diversity would
associate with the lungs of diseased animals. This is be-
cause such diversity would have had notable frequency
in either of the two groups of lung clinical isolates. The
strength of the genotype 2 association with the lungs of
cattle with respiratory disease was driven in large part by
the classification of 150 of 155 (97%) group 1 lung clin-
ical isolates as genotype 2. Between the two groups of
lung clinical isolates, 302 of 317 (95%) of the isolates
classified as genotype 2. Interestingly, of the 15 isolates
that classified as genotype 1, six could not be subtyped
with any statistical significance (Additional file 1). This
may be because they gained alleles from genotype 2 that
enhanced their pathogenicity through recombination,
which may have complicated their placement within a
particular subtype of genotype 1. To that end, recombin-
ation was detected within and across the two genotypes.
However, it is also possible that the 15 isolates, while
present in the lungs of cattle with respiratory disease,
were not the causative agents of that disease. It is not
uncommon to find M. haemolytica together with other
bacteria in the lungs of cattle afflicted with respiratory
disease [34, 35].
Although isolate exposure to antibiotics prior to entry
in this study was unknown, 78 of 156 (50%) of the geno-
type 2 isolates used for ICE sequence association testing
were negative for antibiotic resistance genes found in
ICEPmu1 or ICEMh1. Rather, they contained sequence
homologous to the conserved backbone of ICEPmu1
and ICEMh1 (Additional file 1). Thus, antibiotic selec-
tion does not appear to account for 154 of 156 (99%)
genotype 2 isolates having the conserved backbone ICE
sequence. However, given that genotype 1 isolates were
observed in this study with the backbone ICE sequence
and aminoglycoside, sulfonamide, and tetracycline re-
sistance genes, it is quite possible that the frequency
of ICEs with antibiotic resistance genes could rise in
genotype 1 M. haemolytica in the face of antibiotic
exposure and selection.
While ICEs can have extensive host ranges, they are
capable of preventing host cells from acquiring homologous
ICEs by several different exclusion mechanisms [36]. Given
that virtually all genotype 2 isolates had sequence homolo-
gous to the conserved backbone of ICEPmu1 and ICEMh1,
and that virtually all antibiotic resistance genes that mapped
to variable regions of ICEPmu1 or ICEMh1 placed on the
2b background, ICEs with the conserved backbone of
ICEPmu1 and ICEMh1 that are devoid of antibiotic resist-
ance genes may be providing resistance to the acquisition
of other ICE homologs with antibiotic resistance genes in
2e and 2d M. haemolytica. The same may also be true for
2c M. haemolytica. There were 93 isolates in this study that
were 2c, and none of them had detectable antibiotic resist-
ance genes. However, only two of those isolates belonged to
lung clinical isolate groups and were epidemiologically un-
related, whereas the other 91 isolates were epidemiologi-
cally close to each other.
In stark contrast to all other M. haemolytica subtypes,
every M. haemolytica 2b isolate in this study was posi-
tive for one or more antibiotic resistance gene in
addition to the conserved backbone of ICEPmu1 and
ICEMh1. This may be because the ancestor of extant 2b
M. haemolytica either did not originally have an ICE
homologous to the conserved backbone of ICEPmu1
and ICEMh1 that lacked antibiotic resistance genes, or
replaced it with a homolog that did. It is interesting that
tetH, which encodes an efflux protein that provides
tetracycline resistance [33], was identified on all seven
combinations of resistance genes (Figs. 6 and 7). This in-
fers it may be ancestral in its acquisition order compared
to the other resistance genes. Oxytetracycline was li-
censed for use in the U.S. in product form in 1980 [16].
Additionally, prior to 1980, tetracycline compounds were
used as growth promotants in cattle feed [37]. Therefore,
selective pressure for tetracycline resistance may have
been the result of cattle exposure to tetracyclines in the
U.S. at therapeutic or sub therapeutic levels for decades.
Given that 2b M. haemolytica have seven antibiotic re-
sistance gene combinations with the conserved ICE
backbone, including one that encodes resistance to one
or more antibiotic within six different classes (aminogly-
cosides, sulphonamides, amphenicols, tetracyclines, β –
lactams and macrolides), and has been circulating in the
U.S. since at least 2003, there has been considerable se-
lection for this particular subtype to acquire antibiotic
resistance. While all the subtypes of genotype 2 associate
with the lungs of cattle with respiratory disease, it not
known if one particular subtype is more virulent then
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another. If the ancestor of 2b M. haemolytica did have
an ICE homolog to ICEPmu1 and ICEMh1 that lacked
antibiotic resistance genes, enhanced virulence in com-
parison to other genotype 2 subtypes may have resulted
in an increased exposure to antibiotic treatments, and
selection pressures that overcame any preventative ef-
fects of the ancestral ICE against the acquisition of hom-
ologous ICEs with antibiotic resistance genes.
The clades that define genotypes 1 and 2 are separated
by 13,941 tagging polymorphisms that are distributed
throughout the M. haemolytica genome. The alleles of
these polymorphisms are completely linked to each
other in the genomes of the 1133 isolates included in
this study, and define core genome backbones of geno-
types 1 and 2 M. haemolytica (Additional files 2 and 3).
While these tagging polymorphisms make it quite tract-
able to distinguish between the two genotypes, as any
one of them could be used to classify an M. haemolytica
as belonging to either genotype 1 or 2 (excluding for re-
combination events), they also complicate the identifica-
tion of alleles that are biologically causative for the
association of genotype 2 M. haemolytica with the lungs of
cattle with respiratory disease. This is because alleles that
biologically cause genotype 2 M. haemolytica to have that
association are in linkage with thousands of other poly-
morphism alleles that tag the same genotype backbone.
Of the five subtypes defined in genotype 1, three of
them (1b, 1e, 1i) showed signs of recombination through
blocks of physically close tagging polymorphism alleles.
Conversely, 1c and 1f had relatively few tagging polymor-
phisms that did not fall into blocks (Additional file 6). The
lack of recombination in 1c and 1f indicates that they may
be ancestral to 1b, 1e, and 1i, and that diversification in
genotype 1 was driven by recombination on either the 1c
or 1f background. Similarly, of the four subtypes defined
in genotype 2, two of them had blocks of tagging polymor-
phisms that were indicative of recombination (2b and 2d),
whereas two did not (2c and 2e), (Additional files 7 and
8). Thus, 2c and 2e appear ancestral to 2b and 2d, with re-
combination having driven diversification on either of
their backgrounds to yield 2b and 2d. Consequently, M.
haemolytica diversity in North America appears to be
defined by a split of two major lineages with linear descent
that was later followed by recombination and further di-
versification within both lineages, giving rise to the two
major genotypes and their subtypes.
Conclusions
North American M. haemolytica of cattle place into two
major genotypes that are each defined by multiple sub-
types. Genotype 2 M. haemolytica associate with the
lungs of cattle with respiratory disease, and also with the
conserved sequence backbone of ICEPmu1, ICEMh1,
and other ICE homologs that does not contain antibiotic
resistance genes. Genotype 2, subtype b M. haemolytica
associate with antibiotic resistance genes that map to
variable regions of ICEPmu1 and ICEMh1. This particu-
lar subtype has been circulating in the U.S. since at least
2002 and may be more virulent to cattle than other
genotype 2 subtypes. Tagging polymorphisms were iden-
tified that distinguish the two genotypes and their sub-
types. Rapid identification of virulent antibiotic resistant
strains of M. haemolytica in the field could facilitate in-
terventions that prevent or minimize BRD outbreaks
and ineffective antibiotic treatments, and consequently
reduce therapeutic needs for treating BRD. Additionally,
effective vaccines developed against genotype 2 M. hae-
molytica could further reduce the prevalence of BRD
and subsequent needs for antibiotic treatments.
Methods
Isolates
The genomes of 1133 M. haemolytica isolates were se-
quenced and/or analyzed in this study. The isolates were
categorized into two collections; Zoetis and KSU-
USMARC, and four groups; lung clinical isolates group
1, lung clinical isolates group 2, nasopharyngeal non-
clinical isolates, and clinical and non-clinical isolates
(Table 1, Additional file 1). Groups 1 and 2 of lung clin-
ical isolates consisted of 317 isolates that were part of a
10-year study of antimicrobial susceptibility of bacteria
that cause BRD in the United States and Canada [14],
(Additional file 1). These isolates were originally sent to
Pfizer Animal Health (now Zoetis) by participating vet-
erinary diagnostic laboratories, and their genomes were
sequenced for this study with the permission of both
Zoetis and the diagnostic laboratories that contributed
the isolates. Group 1 of lung clinical isolates consisted of
155 isolates that originated from 35 U.S. States and 5
Canadian Provinces within the years of 2002–2011
(Additional file 1). Group 2 of lung clinical isolates con-
sisted of 162 isolates that originated from 29 U.S. States
and 3 Canadian Provinces. In order for an isolate to be
included in a lung clinical isolate group, it had to origin-
ate from a different state, or a different year within a
state from all other isolates in the group to minimize
epidemiological relatedness.
Of the other 813 isolates used in the study, 810 were
part of a longitudinal study comprised of 180 cattle that
were first sampled for nasopharyngeal bacteria at the
time of their purchase from sale barns located in Athens,
Tennessee (n = 60 cattle), Richmond, Kentucky (n = 60
cattle), or Maryville, Missouri (N = 60 cattle) in the fall
of 2013. The cattle were transported from the sale barns
to a research feeding facility in Kansas where half re-
ceived a metaphylactic treatment for the control of BRD
(gamithromycin (6 mg/kg, subcutaneously adminis-
tered), and half received a saline control. The animals
Clawson et al. BMC Genomics  (2016) 17:982 Page 9 of 14
were then monitored for BRD and periodically sampled
over 28 days for M. haemolytica and other bacteria from
nasopharyngeal swabs and/or bronchoalveolar lavage
fluid and monitored for signs of BRD as previously de-
scribed [34], (Additional file 1).
The 35 isolates comprising the group of nasopharyn-
geal non-clinical isolates from the KSU-USMARC
collection were selected for minimal epidemiological re-
latedness to each other based on geographical origin
(Table 1, Additional file 1). Each of the 35 isolates origi-
nated from the nasopharynx of a different animal that
did not have clinical signs of BRD. Ten of the cattle
sampled were at a sale barn in Athens, Tennessee, 12
were at a sale barn in Maryville, Missouri, and 13 were
at a sale barn in Richmond, Kentucky. The isolates were
obtained from the cattle prior to their transport to the
Kansas research feeding facility and their genomes were
sequenced for this study.
The group of clinical and non-clinical isolates con-
sisted of 781 isolates of which many were epidemiologi-
cally close, or directly related to each other. The
genomes of 505 isolates from this group were sequenced
for this study. The genomes of the remaining 276 iso-
lates were sequenced as previously described [29, 30],
(Additional file 1).
Isolate culture from field collected samples and M.
haemolytica identification
Isolates from the Zoetis collection were originally identi-
fied as M. haemolytica by diagnostic labs located in the
U.S. or Canada, and were further characterized or con-
firmed as M. haemolytica as necessary [14]. Additionally,
the isolates were re-confirmed as M. haemolytica in
2013 via the OmniLog microbial identification system
using GEN III chemistry as per the manufacturer’s
protocol (Biolog, Inc., Hayward, CA, USA).
Nasopharyngeal non-clinical isolates were cultured
from two deep nasopharyngeal swabs that were collect-
ively taken from the left and right nasopharynx of each
animal with double guarded sterile uterine swabs
(VetOne, Boise, Idaho, USA). Swabs from each naso-
pharynx of an animal were either combined in sample
tubes containing liquid Amies media (Becton, Dickinson
and Company, Franklin Lakes, New Jersey, USA) and
transported to the US Meat Animal Research Center at
4 °C, or combined in liquid Amies media with 20% gly-
cerol, frozen at −80 °C, and subsequently transported to
the US Meat Animal Research Center. Aliquots of the
media were spread plated onto both Chocolate agar and
Brain Heart Infusion (BHI) agar plates containing 5%
sheep blood (Hardy Diagnostics, Santa Maria, CA, USA)
and cultured 16–20 h at 37 °C with 5% CO2. Hemolysis,
or lack thereof, on BHI blood agar plates was not an
identification criterion for M. haemolytica, as not all
strains show β-hemolysis on culture plates containing
bovine or ovine blood [38, 39]. Colonies that resembled
M. haemolytica by morphology were cultured for 16–20
h in deep 96-well blocks containing 1 ml of liquid BHI
(Becton, Dickinson and Company, Franklin Lakes, NJ,
USA) per well at 37 °C without CO2 and subsequently
frozen at −80 °C with 10% glycerol. The isolates were
later cultured twice on chocolate agar plates and colonies
from the second culture were identified as M. haemolytica
via Gen III as described above.
Regarding isolates of the clinical and non-clinical
group, those obtained from animals not showing clinical
signs of BRD were obtained and identified as M. haemoly-
tica as described for the group of nasopharyngeal non-
clinical isolates. Isolates within the clinical and non-clinical
group that came from animals diagnosed with respiratory
disease were either obtained from deep nasopharyngeal
swabs or bronchoalveolar lavage samples as previously de-
scribed [34]. The clinical isolates were cultured on trypti-
case soy agar plates with 5% blood, chocolate agar plates,
and MacConkey agar plates in 5% CO2 for 18–24 h as pre-
viously described [34]. The clinical isolates were identified
as M. haemolytica via matrix assisted laser desorption
ionization time-of-flight mass spectrometry (MALDI-TOF
MS), per the manufacturer’s protocol (Bruker Daltonics,
Billerica, MA, USA).
DNA purification, library construction, and sequencing
The genomes of 857 M. haemolytica isolates were
sequenced for this study. This included all 317 isolates
in the Zoetis collection, all 35 isolates in the group of
nasopharyngeal non-clinical isolates, and 505 of the 781
isolates in the group of clinical and non-clinical isolates.
Genomic sequencing of the remaining 276 isolates in
the group of clinical and non-clinical isolates has been
described elsewhere [29, 30]. The sequence data of those
276 isolates were included in this study for nucleotide
polymorphism identification and downstream analyses.
For DNA purification, isolates were cultured in deep
96 well blocks containing 1 mL BHI per well at 37 °C
without supplemental CO2 for 16–20 h. DNA was puri-
fied from the cultures using MO BIO UltraClean® -htp
96 Well Microbial DNA kits per the manufacturer’s in-
structions (Carlsbad, CA, USA). Resulting DNA samples
were quantified with a Promega Quantus Fluorometer
and QuantiFluor Dyes® per the manufacturer instruc-
tions (Promega, Madison, WI, USA). Illumina-based
Nextera XT DNA Library kits were prepared in batches
of 96 as per the manufacturer’s instructions, with
Nextera XT Index Kits (V1) set A which provided 96
unique index combinations (Illumina, San Diego, CA,
USA). Given that the Nextera XT DNA Library kit
protocol involved a PCR step, pre- and post-PCR proce-
dures were conducted in physically separated labs to
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avoid aerosol contamination of samples, reagents, and
libraries. Subsequent to their construction, batches of
96 libraries were combined, and paired-end sequen-
cing was conducted on an Illumina MiSeq instrument
with either MiSeq Reagent Kit version 2 (2 × 250 bp,
500 cycles) or version 3 (2 × 300 bp, 600 cycles), (Illumina,
San Diego, CA, USA).
Quality control checks of isolate sequence
Sequence coverage for each isolate was determined to
ensure that a minimum of 10× sequence per genome
was attained. The coverage was calculated using total
bases of sequence per isolate divided by 2.6 million,
which is the typical genome size for known M. haemoly-
tica isolates in GenBank. Any isolate that did not have
10× sequence per genome was re-sequenced to achieve
that coverage or higher.
The DNA sequence of each isolate was also checked
for evidence of contamination and/or isolate misidentifi-
cation using Geneious software and a series of BLAST
analyses. Geneious (version 8.1.5), [40], was used to map
the sequence reads from each isolate using the Geneious
mapper program with Medium/Fast Sensitivity and fine
tuning of up to 5× iterations. The reads were mapped to
an available complete, finished, circular reference gen-
ome of M. haemolytica strain USDA-ARS-USMARC-
183 which was isolated from a 1991 BRD case in Kansas,
USA ([28], GenBank: CP004752). Because the Illumina
platform generated paired-end reads of clonal sequence
[41], the mapped reads could be checked for the pres-
ence of nucleotide polymorphisms where both alleles
were observed between reads from the same isolate, and
were not the result of mapping or sequencing errors.
Detection of these polymorphisms was an indication that
more than one type of M. haemolytica, or bacterial spe-
cies was represented in the library. Any M. haemolytica
isolate found to be represented by a library that yielded
sequences indicative of different strain types of M. hae-
molytica, or other bacterial species, was re-cultured for
isolation of all discernable M. haemolytica types. The
resulting isolates were subsequently sequenced. Add-
itionally, for each isolate sequenced in this study, full
length 16S rDNA and the leukotoxin gene (lktA), as well
as random regions selected throughout the genome were
compared to M. haemolytica reference genomes present
in NCBI GenBank using BLASTN [42], for in silico
confirmation that the isolates were M. haemolytica.
Genome-wide nucleotide polymorphism identification
and genotyping
MiSeq-produced sequence reads of the 857 M. haemoly-
tica isolates sequenced in this study, as well as those of
the 276 previously sequenced M. haemolytica, were
mapped to the genome of M. haemolytica strain USDA-
ARS-USMARC-183 using Bowtie 2 (v2,2,1) with default
and the “very-sensitive-local” arguments at Intrepid
Bioinformatics Inc (Louisville, KY, USA). Standard align-
ment post-processing of the mapped reads which in-
cluded the marking of PCR duplicates and realignment
of insertion deletion polymorphisms was done via done
Genome Analysis Toolkit (GATK) v1.5-32-g2761da9.
“Singleton” nucleotide polymorphisms, where the minor
allele was observed in only one isolate, as well as inser-
tion deletion polymorphisms, were not included in the
dataset. All isolates were initially genotyped for nucleo-
tide polymorphisms identified throughout the genome.
Nucleotide polymorphisms identified within integrated
phage sites and duplicated genomic regions of strain
USDA-ARS-USMARC-183 were not included in subse-
quent analyses due the inherent difficulty in accurately
mapping short sequence reads to repetitive sequence
that can create polymorphism artifacts [43, 44].
Identification of ICE sequence
ICE sequences with or without the macrolide resistance
genes erm(42), msr(E), and mph(E) have been reported
for the 276 M. haemolytica isolates included in this
study that were previously sequenced [29]. The 857 M.
haemolytica isolates sequenced in this study, and the
additional 276 previously sequenced isolates, were quer-
ied for ICE and antibiotic resistance gene sequences by
mapping their sequence reads to three homologous ICE
sequences using Geneious (version 8.1.5). The three
ICEs were ICEPmu1, which was identified within the
genome of P. multocida 36950 (GenBank: CP003022),
ICEMh1, which was identified within the genome of M.
haemolytica isolate M42548 (GenBank: CP005383), and
a putative ICE identified in M. haemolytica isolate
USDA-ARS-USMARC-183 that is homologous to the
conserved sequence backbone of ICEPmu1 and ICEMh1
and does not contain antibiotic resistance genes [23].
The presence or absence of ICE sequence, as well as
antibiotic resistance genes present in ICEPmu1 and
ICEMh1 was determined for each isolate based on the
observation of reads mapped to annotated regions of
those reference sequences.
Trees and networks constructed from concatenated
nucleotide polymorphism genotypes
For each isolate, concatenated nucleotide polymorphism
genotypes were created from their corresponding alleles
of genome-wide polymorphisms identified in this study. A
Neighbor-Joining tree was generated from concatenated
nucleotide polymorphism genotypes of all 1133 isolates
involved in this study (Fig. 1). The nucleotide polymor-
phisms used to generate the concatenated nucleotide
polymorphism genotypes for generation of the tree each
had allele genotypes scored for 95% or more of the
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isolates. The alleles were formatted into an alignment in
MacVector (version 14.5.1), [45] using clustal W. A
Neighbor-Joining tree was generated from the alignment
using the following programs: Seqboot, Dnadist, Neighbor,
and Consense which are all part of PHYLIP (version 3.69),
[46]. An F84 model of substitution with a transition trans-
version ratio of 2 was used to generate the tree, which was
bootstrapped 100 times. The tree was viewed using the
program Dendroscope (version 3.5.7), [47, 48].
A Neighbor-Joining network was generated from the
concatenated nucleotide polymorphism genotypes of 521
genotype 1 isolates (Fig. 2), and another from those of
600 genotype 2 isolates (Fig. 3). The nucleotide polymor-
phisms used to generate the networks had allele geno-
types scored for 90% or more of the isolates. The
nucleotide polymorphism genotypes of the 521 genotype
1 isolates represented in Fig. 2 were tested for recombin-
ation using a phi test [49], in SplitsTree4 (version
4.12.3), [50], as were those of the 600 genotype 2 isolates
represented in Fig. 3. The networks were also made in
SplitsTree4 with an F84 model of substitution and a
transition/transversion ratio of 2. Support for clusters
identified in the networks was determined using IQ-
TREE (version 1.3.10), which is a maximum-likelihood
phylogeny platform [51]. For each isolate group, Model-
Finder was used within IQ-TREE to find the optimal
model of substitution. For the networks of Figs. 2 and 3,
GTR +G and SYM+G models of substitution were
used, respectively, to generate the maximum-likelihood
trees. Support within the trees was determined in IQ-
TREE with 1000 dataset replicates using SH-aLRTs, [52],
and ultrafast bootstraps [53].
Statistical testing
Isolates comprising the two following groups were
used for statistical testing; lung clinical isolates group
1 (n = 155), and the group of nasopharyngeal non-
clinical isolates (n = 35). Two-way contingency table
analyses were conducted to test for an association be-
tween genotype 2 M. haemolytica with 1) the lungs
of diseased animals, and 2) the presence of ICE se-
quence homologous to the conserved sequence back-
bones of ICEPmu1, ICEMh1 and other homologs
(http://statpages.info/ctab2x2.html), [54]. Additionally,
a 2-way contingency table analysis was conducted to
test for an association between genotype 2b M. hae-
molytica and antibiotic resistance genes found in vari-
able regions of ICEPmu1 or ICEMh1. Only group 1
lung clinical isolates that were genotype 2 with sub-
types supported by SH-aLRT and ultrafast bootstrap
values were used for this analyses (n = 147). The
group of nasopharygeal non-clinical isolates was not
included due to the low frequency of genotype 2 M.
haemolytica in the group (n = 6).
Additional files
Additional file 1: Table of M. haemolytica isolates used in this study. For
each isolate, the table contains information regarding a Minilims identifier
number for the isolate and for the isolate library, state or province of origin,
year of isolation, the collection the isolate belongs to, an AHDRCC identifier
number, the group the isolate belongs to, use in the study, genotype
and subtype designation, ICE and antibiotic resistance gene sequence
information. (XLSX 148 kb)
Additional file 2: Table of nucleotide polymorphism allele locations and
genotypes used to initially type all 1133 M. haemolytica isolates (first
table). Due to the size of the dataset this is the first of two tables that
contain the genotypes (Additional files 2 and 3). The table contains the
locations and allele scores for 11,306 of 16,447 nucleotide polymorphisms
that were used to generate the tree of Fig. 1. Each polymorphism was
unambiguously scored in 95% or more of the isolates. (ZIP 4344 kb)
Additional file 3: Table of nucleotide polymorphism allele locations and
genotypes used to initially type all 1133 M. haemolytica isolates (second
table). Due to the size of the dataset this is the second of two tables that
contain the genotypes (Additional files 2 and 3). The table contains the
locations and allele scores for 5141 of 16,447 nucleotide polymorphisms
that were used to generate the tree of Fig. 1. Each polymorphism was
unambiguously scored in 95% or more of the isolates. (CSV 11580 kb)
Additional file 4: Table of nucleotide polymorphism allele locations and
genotypes used to type genotype 1 M. haemolytica isolates (first table).
Due to the size of the dataset, this is the first of two tables that contain
the genotypes (Additional files 4 and 5). The table contains the locations
and allele scores for 11,712 of the 16,888 nucleotide polymorphisms used
to type genotype 1 M. haemolytica and construct the network of Fig. 2.
Each polymorphism was unambiguously scored in 90% or more of the
isolates. (CSV 12221 kb)
Additional file 5: Table of nucleotide polymorphism allele locations and
genotypes used to type genotype 1 M. haemolytica isolates (second table).
Due to the size of the dataset, this is the second of two tables that contain
the genotypes (Additional files 4 and 5). The table contains the locations
and allele scores for 5176 of the 16,888 nucleotide polymorphisms used to
type genotype 1 M. haemolytica and construct the network of Fig. 2. Each
polymorphism was unambiguously scored in 90% or more of the isolates.
(CSV 5410 kb)
Additional file 6: Table of nucleotide polymorphisms with both alleles
observed in genotype 1 M. haemolytica isolates. The table shows informative
and tagging polymorphisms for the subtypes of genotype 1. (XLSX 87 kb)
Additional file 7: Table of nucleotide polymorphism allele locations and
genotypes used to score genotype 2 M. haemolytica isolates (first table).
Due to the size of the dataset, this is the first of two tables that contain
the genotypes (Additional files 7 and 8). The table contains the locations
and allele scores for 16,246 of 24,475 nucleotide polymorphisms used to
type genotype 2 M. haemolytica and construct the network of Fig. 3.
Each polymorphism was unambiguously scored in 90% or more of the
isolates. (ZIP 3413 kb)
Additional file 8: Table of nucleotide polymorphism allele locations and
genotypes used to score genotype 2 M. haemolytica isolates (second
table). Due to the size of the dataset, this is the second of two tables that
contain the genotypes (Additional files 8 and 9). The table contains the
locations and allele scores for 8229 of 24,475 nucleotide polymorphisms
used to type genotype 2 M. haemolytica and construct the network of
Fig. 3. Each polymorphism was unambiguously scored in 90% or more of
the isolates. (CSV 9995 kb)
Additional file 9: Table of nucleotide polymorphisms with both alleles
observed in genotype 2 M. haemolytica isolates. The table shows informative
and tagging polymorphisms for the subtypes of genotype 2. (XLSX 131 kb)
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